EUVIMEDScopri EUVIMED
Crossref

Aglycin ameliorates nonalcoholic fatty liver disease through modulation of the gut microbiota, restoration of the intestinal barrier, and inhibition of hepatic inflammation in mice

Leyan Zhou, Juan Li, Wei Wei, Xiaomin Ma, Zhuyan Xu, Limin Ouyang, Yutong Guan, Xue Jia, Qiming Wu, Min Zhao

Food & Function · 2025

DOI: 10.1039/d5fo03751d ↗

At a glance

Journal article in Food & Function, 2025. Written by Leyan Zhou and 9 co-authors. Institution: Department of Nutrition and Food Hygiene, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China. …. Major MEDLINE topics: Gastrointestinal Microbiome, Non-alcoholic Fatty Liver Disease, Soybean Proteins. Cited 2 times so far (Crossref); 79 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Aglycin alleviates NAFLD by modulating gut microbiota composition, restoring intestinal barrier function, and reducing hepatic inflammation.

Subjects

MeSH terms (MEDLINE)

Gastrointestinal MicrobiomeNon-alcoholic Fatty Liver DiseaseSoybean ProteinsAnimalsMiceMaleMice, Inbred C57BLLiverDiet, High-FatDisease Models, AnimalIntestinal MucosaInflammationToll-Like Receptor 4NF-kappa B

Substances

Soybean ProteinsToll-Like Receptor 4NF-kappa B

Authors and institutions

  • Department of Nutrition and Food Hygiene, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China. zhaomin1986zm@126.com.
  • School of Public Health, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, 250117, Shandong, China.
  • College of Food Science and Engineering, Northwest A&F University, Yangling, 712100, Shaanxi, China.
  • Zhong Shi Du Qing (Shandong) Biotechnology Company, Heze, 274108, Shandong, China.
  • Center for Experimental Public Health and Preventive Medicine Education, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, 250012, Shandong, China.
  • Nutrilite Health Institute, Shanghai, 201203, China. Hudson.wu@amway.com.

Funding

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province

Cite

APA

Zhou, L., Li, J., Wei, W., Ma, X., Xu, Z., Ouyang, L., Guan, Y., Jia, X., Wu, Q., & Zhao, M. (2025). Aglycin ameliorates nonalcoholic fatty liver disease through modulation of the gut microbiota, restoration of the intestinal barrier, and inhibition of hepatic inflammation in mice. Food & Function. https://doi.org/10.1039/d5fo03751d

Vancouver

Zhou L, Li J, Wei W, Ma X, Xu Z, Ouyang L, et al. Aglycin ameliorates nonalcoholic fatty liver disease through modulation of the gut microbiota, restoration of the intestinal barrier, and inhibition of hepatic inflammation in mice. Food & Function. 2025. doi:10.1039/d5fo03751d

BibTeX
@article{Zhou2025,
  author = {Zhou, Leyan and Li, Juan and Wei, Wei and Ma, Xiaomin and Xu, Zhuyan and Ouyang, Limin and Guan, Yutong and Jia, Xue and Wu, Qiming and Zhao, Min},
  title = {Aglycin ameliorates nonalcoholic fatty liver disease through modulation of the gut microbiota, restoration of the intestinal barrier, and inhibition of hepatic inflammation in mice},
  journal = {Food & Function},
  year = {2025},
  doi = {10.1039/d5fo03751d}
}
Start for free →